SPRAVATO® consultations
Adults with depression that has not responded adequately to prior treatment can request an evaluation to discuss whether supervised esketamine nasal spray may be appropriate. The assessment includes treatment history, medications and safety considerations.
Treatment is administered in a certified healthcare setting, not at home. Monitoring lasts at least two hours after administration, with discharge determined clinically. Arrange transportation home; do not drive until the next day after a restful sleep.
